Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 32,238 shares at $54.48 ($1.8M) on 2010-03-01, disclosed to the SEC on 2010-03-02.
Scheduled sale ($1.8M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.12 | 9,154 | $495K | 28.3% |
| 2 | $54.35 | 2,158 | $117K | 6.7% |
| 3 | $54.38 | 1,000 | $54K | 3.1% |
| 4 | $54.39 | 2,900 | $158K | 9.0% |
| 5 | $54.40 | 2,100 | $114K | 6.5% |
| 6 | $54.41 | 1,400 |
| $76K |
| 4.3% |
| 7 | $54.42 | 3,500 | $190K | 10.9% |
| 8 | $54.43 | 1,226 | $67K | 3.8% |
| 9 | $54.47 | 1,100 | $60K | 3.4% |
| 10 | $54.48 | 100 | $5K | 0.3% |
| 11 | $54.49 | 100 | $5K | 0.3% |
| 12 | $54.51 | 2,900 | $158K | 9.0% |
| 13 | $54.52 | 4,500 | $245K | 14.0% |
| 14 | $54.53 | 100 | $5K | 0.3% |
| Total | $54.35 avg | 32,238 | $1.8M | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |